Financials
- Market Capitalization 329.3 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.61
Rapporto prezzo/fatturato
54.94
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3212 | STRO Sutro Biopharma, Inc. - Common Stock | 20.45 USD | -4.04% | +1.84% | -14.69% | +17.60% | 339.08 M USD | ||
| 3227 | ABEO Abeona Therapeutics Inc. - Common Stock | 5.82 USD | -1.69% | -5.06% | -9.77% | -14.91% | 332.81 M USD | ||
| 3257 | VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.33 USD | +0.76% | +0.38% | +4.51% | -3.62% | 322.27 M USD | ||
| 3276 | IMRX Immuneering Corporation - Class A Common Stock | 4.89 USD | -2.00% | -8.26% | +17.83% | -13.30% | 316.37 M USD |